CAR-T Therapy for Non-Hodgkin Lymphomas (DLBCL, FL, MCL) at Sheba Medical Center

• Terapia con cellule CAR-T
• 3 pasti al giorno dal nutrizionista
• Servizi infermieristici 24 ore su 24
• TAC
• Elettrocardiogramma (ECG)
• Consultazione con un medico
• Esami del sangue
• Esame di follow-up
• Ecografia
• Ecocardiografia
• Esame di biochimica del sangue
• PET/TC
• Consultazione con un oncologo
• Consultazione con un ematologo
• Visita di follow-up
• Consultazione con un immunologo
• Consultazione con un neurologo
• Consultazione con un cardiologo
• Consultazione con un ematologo pediatrico
• Consultazione con un oncoematologo
• Emocromo completo con marcatori tumorali e proteinogramma
• Angiografia TC

• 21 giorni in ospedale
• 7 giorni in albergo

• Trasferimento aeroporto-clinica-aeroporto

CAR-T Therapy for Non-Hodgkin Lymphomas (DLBCL, FL, MCL) at Sheba Medical Center

For patients facing relapsed or resistant Non-Hodgkin lymphoma, finding the right treatment center can make a life-changing difference.

Sheba Medical Center, one of the world’s leading hospitals, offers advanced CAR-T cell therapy, providing new hope when standard treatments are no longer effective.

Sheba specializes in treating DLBCL, Follicular Lymphoma (FL), and Mantle Cell Lymphoma (MCL) with a highly personalized approach, combining cutting-edge science, speed, and clinical expertise.

A Faster Path to Treatment When Time Matters Most
At Sheba, the entire CAR-T process is performed on-site, without delays caused by external laboratories.

• T-cells are collected (apheresis)
• Genetically engineered at Sheba’s Advanced Biotherapy Center
• Reinfused to target and destroy lymphoma cells

This streamlined approach allows treatment to begin in approximately 10 days, significantly faster than many international centers.
CAR-T therapy acts as a “living drug”, continuing to work inside the body and offering the potential for long-term remission.

All patients are treated under the leadership of Prof. Arnon Nagler, a world-renowned expert in hemato-oncology.

Proven Results That Offer Real Hope

Even in complex and advanced cases, CAR-T therapy at Sheba has demonstrated high remission rates

• Up to 90% in pediatric patients

These outcomes provide a meaningful second chance for patients who have exhausted other options.

Why Patients Choose Sheba

• Rapid access to treatment – no waiting weeks for cell production
• Extensive experience – one of the largest CAR-T programs in the region
• Dedicated CAR-T units – with 24/7 expert monitoring
• Multidisciplinary care – leading specialists working together on every case
• Full international support – from medical review to travel and coordination

Comprehensive, Personalized Care

Each patient undergoes a complete evaluation, including advanced imaging, genetic and molecular testing, and full medical assessment, ensuring the most effective, tailored treatment plan.
Services are available in English, Russian, and Arabic, making the experience smooth and supportive for international patients.

A Global Leader in Advanced Cancer Care

By combining speed, innovation, and world-class expertise, Sheba delivers one of the most advanced and accessible CAR-T programs for lymphoma patients worldwide, offering not just treatment, but a real opportunity for remission and renewed quality of life.

• Coordinatore medico personale
• Organizzazione dei viaggi medici — prenotazione di biglietti aerei e camere d'albergo a prezzi speciali per i partner
• Tutela degli interessi dei pazienti durante il viaggio medico